These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 25258651)
1. Circulating microRNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer. Wang J; Raimondo M; Guha S; Chen J; Diao L; Dong X; Wallace MB; Killary AM; Frazier ML; Woodward TA; Wang J; Sen S J Cancer; 2014; 5(8):696-705. PubMed ID: 25258651 [TBL] [Abstract][Full Text] [Related]
2. MicroRNAs in stool samples as potential screening biomarkers for pancreatic ductal adenocarcinoma cancer. Yang JY; Sun YW; Liu DJ; Zhang JF; Li J; Hua R Am J Cancer Res; 2014; 4(6):663-73. PubMed ID: 25520858 [TBL] [Abstract][Full Text] [Related]
3. Pancreatic Juice Exosomal MicroRNAs as Biomarkers for Detection of Pancreatic Ductal Adenocarcinoma. Nakamura S; Sadakari Y; Ohtsuka T; Okayama T; Nakashima Y; Gotoh Y; Saeki K; Mori Y; Nakata K; Miyasaka Y; Onishi H; Oda Y; Goggins M; Nakamura M Ann Surg Oncol; 2019 Jul; 26(7):2104-2111. PubMed ID: 30820789 [TBL] [Abstract][Full Text] [Related]
4. Extracellular vesicle-derived microRNAs in pancreatic juice as biomarkers for detection of pancreatic ductal adenocarcinoma. Nesteruk K; Levink IJM; de Vries E; Visser IJ; Peppelenbosch MP; Cahen DL; Fuhler GM; Bruno MJ Pancreatology; 2022 Jun; 22(5):626-635. PubMed ID: 35613957 [TBL] [Abstract][Full Text] [Related]
5. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma. Munding JB; Adai AT; Maghnouj A; Urbanik A; Zöllner H; Liffers ST; Chromik AM; Uhl W; Szafranska-Schwarzbach AE; Tannapfel A; Hahn SA Int J Cancer; 2012 Jul; 131(2):E86-95. PubMed ID: 21953293 [TBL] [Abstract][Full Text] [Related]
6. Novel Circulating miRNA Signatures for Early Detection of Pancreatic Neoplasia. Vila-Navarro E; Duran-Sanchon S; Vila-Casadesús M; Moreira L; Ginès À; Cuatrecasas M; Lozano JJ; Bujanda L; Castells A; Gironella M Clin Transl Gastroenterol; 2019 Apr; 10(4):e00029. PubMed ID: 31009404 [TBL] [Abstract][Full Text] [Related]
7. Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients. Sun B; Liu X; Gao Y; Li L; Dong Z Br J Biomed Sci; 2016 Oct; 73(4):152-157. PubMed ID: 27922430 [TBL] [Abstract][Full Text] [Related]
8. Emerging Horizons in the Diagnosis of Pancreatic Cancer: The Role of Circulating microRNAs as Early Detection Biomarkers for Pancreatic Ductal Adenocarcinoma. Reyaz I; Khan B; James N; Azhar H; Rehman A; Younas MW; Rashid H; Al-Shaikhly FF; Almomani MM; I Kh Almadhoun MK; Abdullah Yahya N; Bokhari SFH; Shehzad A Cureus; 2024 Jan; 16(1):e53023. PubMed ID: 38410292 [TBL] [Abstract][Full Text] [Related]
9. Circulating microRNAs as diagnostic biomarkers for pancreatic cancer. Le Large TY; Meijer LL; Prado MM; Kazemier G; Frampton AE; Giovannetti E Expert Rev Mol Diagn; 2015; 15(12):1525-9. PubMed ID: 26567751 [TBL] [Abstract][Full Text] [Related]
10. Detection of differentially expressed microRNAs in serum of pancreatic ductal adenocarcinoma patients: miR-196a could be a potential marker for poor prognosis. Kong X; Du Y; Wang G; Gao J; Gong Y; Li L; Zhang Z; Zhu J; Jing Q; Qin Y; Li Z Dig Dis Sci; 2011 Feb; 56(2):602-9. PubMed ID: 20614181 [TBL] [Abstract][Full Text] [Related]
11. miR-3940-5p/miR-8069 ratio in urine exosomes is a novel diagnostic biomarker for pancreatic ductal adenocarcinoma. Yoshizawa N; Sugimoto K; Tameda M; Inagaki Y; Ikejiri M; Inoue H; Usui M; Ito M; Takei Y Oncol Lett; 2020 Apr; 19(4):2677-2684. PubMed ID: 32218818 [TBL] [Abstract][Full Text] [Related]
12. Contribution of a Circulating 2'-O-methylated MicroRNA Panel to the Diagnosis of Pancreatic Ductal Adenocarcinoma. Yang Z; Huang J; Wu X; Zhou Y; Tang Y; Zhu Y; Li B; Chen X; Yao W J Cancer; 2024; 15(6):1583-1592. PubMed ID: 38370369 [No Abstract] [Full Text] [Related]
13. MiR-10a in Pancreatic Juice as a Biomarker for Invasive Intraductal Papillary Mucinous Neoplasm by miRNA Sequencing. Kuratomi N; Takano S; Fukasawa M; Maekawa S; Kadokura M; Shindo H; Takahashi E; Hirose S; Fukasawa Y; Kawakami S; Hayakawa H; Takada H; Nakakuki N; Kato R; Yamaguchi T; Nakayama Y; Kawaida H; Kono H; Inoue T; Kondo T; Ichikawa D; Enomoto N Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809988 [TBL] [Abstract][Full Text] [Related]
14. Circulating microRNAs in serum of human K-ras oncogene transgenic rats with pancreatic ductal adenocarcinomas. Yabushita S; Fukamachi K; Tanaka H; Sumida K; Deguchi Y; Sukata T; Kawamura S; Uwagawa S; Suzui M; Tsuda H Pancreas; 2012 Oct; 41(7):1013-8. PubMed ID: 22513294 [TBL] [Abstract][Full Text] [Related]
15. Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Patients Undergoing Surgical Resection. Gablo N; Trachtova K; Prochazka V; Hlavsa J; Grolich T; Kiss I; Srovnal J; Rehulkova A; Lovecek M; Skalicky P; Berindan-Neagoe I; Kala Z; Slaby O J Clin Med; 2020 Jul; 9(8):. PubMed ID: 32751582 [TBL] [Abstract][Full Text] [Related]
16. Noninvasive urinary miRNA biomarkers for early detection of pancreatic adenocarcinoma. Debernardi S; Massat NJ; Radon TP; Sangaralingam A; Banissi A; Ennis DP; Dowe T; Chelala C; Pereira SP; Kocher HM; Young BD; Bond-Smith G; Hutchins R; Crnogorac-Jurcevic T Am J Cancer Res; 2015; 5(11):3455-66. PubMed ID: 26807325 [TBL] [Abstract][Full Text] [Related]
17. Pre-operative Plasma miR-21-5p Is a Sensitive Biomarker and Independent Prognostic Factor in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Resection. Karasek P; Gablo N; Hlavsa J; Kiss I; Vychytilova-Faltejskova P; Hermanova M; Kala Z; Slaby O; Prochazka V Cancer Genomics Proteomics; 2018; 15(4):321-327. PubMed ID: 29976637 [TBL] [Abstract][Full Text] [Related]
18. miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinoma. Alemar B; Izetti P; Gregório C; Macedo GS; Castro MA; Osvaldt AB; Matte U; Ashton-Prolla P Pancreas; 2016 Jan; 45(1):84-92. PubMed ID: 26262588 [TBL] [Abstract][Full Text] [Related]
19. The Combination of MiRNA-196b, LCN2, and TIMP1 is a Potential Set of Circulating Biomarkers for Screening Individuals at Risk for Familial Pancreatic Cancer. Bartsch DK; Gercke N; Strauch K; Wieboldt R; Matthäi E; Wagner V; Rospleszcz S; Schäfer A; Franke FS; Mintziras I; Bauer C; Grote T; Figiel J; Di Fazio P; Burchert A; Reinartz S; Pogge von Strandmann E; Klöppel G; Slater EP J Clin Med; 2018 Sep; 7(10):. PubMed ID: 30241369 [TBL] [Abstract][Full Text] [Related]
20. Serum miR-210-3p can be used to differentiate between patients with pancreatic ductal adenocarcinoma and chronic pancreatitis. Guz M; Jeleniewicz W; Cybulski M; Kozicka J; Kurzepa J; Mądro A Biomed Rep; 2021 Jan; 14(1):10. PubMed ID: 33235725 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]